IL1B and myeloid sarcoma: Many studies found a relationship between IL-1β and the severity of MS, whereby increased levels of IL-1β in MS patients’ cerebrospinal fluid were linked to the relapse-onset MS progression (Feakes et al., 2000; Niino et al., 2001; de Jong et al., 2020).